Month: January 2019

General Motors Co on Thursday named Mark Reuss president, effective immediately, tapping into his experience in driving the company’s global product development.

…read more […]

Food group Nestle said on Thursday a ruling by India’s Supreme Court marked a partial victory in its row with the government over Maggi noodles.

…read more […]

Oil prices rebounded on Thursday after an early slide, helped by dollar weakness and signs of output cuts by the world’s top crude exporter Saudi Arabia that eased concerns about a glut.

…read more […]

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating a major pharma company with several blockbuster cancer drugs as competition in the immunotherapy space heats up.

…read more […]

Apple Inc shares fell as much as 9 percent in early trading after the iPhone maker blamed weak China demand for its revenue shortfall in the holiday quarter, a clear sign of the company’s struggles in the world’s largest smartphone market.

…read more […]

The number of Americans filing applications for jobless benefits increased more than expected last week, but the underlying trend continued to point to labor market strength despite ongoing financial market volatility.

…read more […]

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating a pharma company with several blockbuster cancer drugs and making it one of the biggest mergers on record in the sector.

…read more […]

U.S. stock index futures tumbled on Thursday after Apple Inc stunned investors with a rare sales warning that inflamed fears that the Sino-U.S. trade war and a slowing China economy would eat into corporate profits more than expected.

…read more […]

General Motors Co on Thursday reported that U.S. new vehicle sales fell 2.7 percent in the fourth quarter, with declines across most of its brands as American auto sales appear set to weaken in 2019.

…read more […]

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion in a cash-and-stock deal, creating a powerhouse that will have several blockbuster cancer drugs.

…read more […]

U.S. stock index futures fell sharply on Thursday after Apple Inc stunned investors with its first sales warning in more than a decade, deepening fears about a slowdown in China’s economy and its impact on corporate profits.

…read more […]

Shanghai student Xu Yechuyi wanted to buy a new iPhone last year but couldn’t afford one at Apple Inc’s flagship store, so she opted for a used, three-year-old iPhone 6S at less than a third of the sticker price.

…read more […]

Apple’s rare warning on revenue rocked financial markets on Thursday, as investors sought safety in bonds and less risky assets amid renewed concerns about slowing global economic and corporate growth.

…read more […]

Apple’s first sales warning in nearly 12 years sent European shares sliding on Thursday, with the tech sector particularly badly bruised as chipmakers that supply the iPhone maker fell sharply.

…read more […]

Apple’s rare warning on revenue rocked financial markets on Thursday, reigniting concerns about slowing global economic and corporate growth and potential damage from Washington’s protracted trade row with Beijing.

…read more […]